| Fund Name: |
Invesco Pharmaceuticals ETF |
| Issuer: |
Invesco |
| Total Net Assets: |
$451,180,298 |
| Inception: |
06/23/2005 |
| Related Index: |
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November. |
| ETF Category: |
Health |
| Expense Ratio: |
0.57% |
 |
| Net Asset Value: |
$124.85 |
| Recent NAV Premium: |
0.00% |
| NAV Symbol: |
PJP.NV |
| Number of Holdings: |
33 |
| Annualized Yield: |
0.85% |
| Annualized Distribution: |
1.06 |
| PJP Dividend History » |
|
